Cargando…

Establishment of a regression model of bone metabolism markers for the diagnosis of bone metastases in lung cancer

BACKGROUND: The aim of this study was to establish a regression equation model of serum bone metabolism markers. We analyzed the diagnostic value of bone metastases in lung cancer and provided laboratory evidence for the early clinical treatment of bone metastases in lung cancer. METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhongliang, Yang, Guangyu, Pang, Zhenzhen, Liang, Jiawei, Wang, Weizhong, Zhou, Yonglie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830744/ https://www.ncbi.nlm.nih.gov/pubmed/33487166 http://dx.doi.org/10.1186/s12957-021-02141-5

Ejemplares similares

Usefulness of Bone Metabolic Markers in the Diagnosis of Bone Metastasis from Lung Cancer
por: Chung, Jae Ho, et al.
Publicado: (2005)

Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer.
por: Aruga, A., et al.
Publicado: (1997)

Mechanisms, Diagnosis and Treatment of Bone Metastases
por: Ban, Jozef, et al.
Publicado: (2021)

Editorial: Diagnosis and treatment of bone metastases
por: Pu, Feifei, et al.
Publicado: (2023)

Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)

Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
por: Massy, E, et al.
Publicado: (2021)

Well-Designed Bone-Seeking Radiolabeled Compounds for Diagnosis and Therapy of Bone Metastases
por: Ogawa, Kazuma, et al.
Publicado: (2015)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

What is the relationship between bone turnover markers and skeletal-related events in patients with bone metastases from solid tumors and in patients with multiple myeloma? A systematic review and meta-regression analysis
por: Jiang, Zefei, et al.
Publicado: (2020)

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
por: Gong, Linlin, et al.
Publicado: (2019)

Deep learning based automated diagnosis of bone metastases with SPECT thoracic bone images
por: Lin, Qiang, et al.
Publicado: (2021)

(68)Ga-P15-041, A Novel Bone Imaging Agent for Diagnosis of Bone Metastases
por: Guo, Rui, et al.
Publicado: (2021)

Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation
por: Zhao, Hanqing, et al.
Publicado: (2022)

Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases
por: Wood, Steven L., et al.
Publicado: (2020)

Targeted Treatments of Bone Metastases in Patients with Lung Cancer
por: Hirsh, Vera
Publicado: (2014)

Incidence and consequences of bone metastases in lung cancer patients
por: Kuchuk, Michael, et al.
Publicado: (2013)

The risk factors of bone metastases in patients with lung cancer
por: Zhou, Yang, et al.
Publicado: (2017)

The Impact of Lung Carcinoma Histology on the Frequency of Bone Metastases
por: Oliveira, Marcelo Bragança dos Reis, et al.
Publicado: (2019)

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Thyroid Metastases in Bone
por: Cruickshank, M. M.
Publicado: (1938)

Bone Metastases: An Overview
por: Macedo, Filipa, et al.
Publicado: (2017)

Editorial: Bone Metastases
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)

Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases
por: Li, Ming, et al.
Publicado: (2023)

Myostatin and markers of bone metabolism in dermatomyositis
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2021)

Evaluation of the clinical value of bone metabolic parameters for the screening of osseous metastases compared to bone scintigraphy
por: Schoenberger, Johann, et al.
Publicado: (2004)

Effects of palliative radiotherapy and bisphosphonate usage on bone turnover marker levels in cancer patients with osteolytic bone metastases
por: Göksel, Fatih, et al.
Publicado: (2021)

Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis
por: Pantano, Francesco, et al.
Publicado: (2022)

Deep learning–based diagnosis of osteoblastic bone metastases and bone islands in computed tomograph images: a multicenter diagnostic study
por: Xiong, Yuchao, et al.
Publicado: (2023)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
por: Krawczyk, Paweł, et al.
Publicado: (2013)

Establishment of a serological molecular model for the early diagnosis and progression monitoring of bone metastasis in lung cancer
por: Teng, Xiaoyan, et al.
Publicado: (2020)

A challenging diagnosis of malignant mesothelioma with osteosarcomatous differentiation metastasizing to bone
por: Brown, Michael, et al.
Publicado: (2020)

Trends in Diagnosis and Surgical Treatment of Bone Metastases among Orthopedic Surgeons
por: Ciechanowicz, Dawid, et al.
Publicado: (2022)

Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?
por: Farach-Carson, Mary C., et al.
Publicado: (2017)

Bone metastases in thyroid cancer
por: Iñiguez-Ariza, Nicole M., et al.
Publicado: (2020)

Establishing the Prevalence of Osteomalacia in Arab Adolescents Using Biochemical Markers of Bone Health
por: Al-Daghri, Nasser M., et al.
Publicado: (2022)

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
por: Chen, Lihui, et al.
Publicado: (2022)

Positron emission tomography/computed tomography is superior to bone scan in the diagnosis of bone metastases of malignant prostate tumors
por: Sun, Yue, et al.
Publicado: (2022)

Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron)
por: Heianna, Joichi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hp9smqi2bh0374k72oi11ejeuh